FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20200622E00334
1. Date of relevant event: 17/06/2020
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 06160
4. Name of listed corporation: BeiGene, Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,010,673,263
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Krishana
(Other names) Ranjeev
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
11033The number of shares in which you are interested has increased because:
you became the holder of, wrote or issued equity derivatives under which (choose one):
you have a right to receive from another person an amount if the price of the underlying shares is above a certain level
 
 
 		 45,383  USD       
3104Services
 
Short position 
 
 
 		            
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position291,3170.03
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position336,7000.03
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2106Person having a security interest in shares
Long position336,700
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
19/04/201718/04/2027USD0USD2.840USD2.840199,992
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
06/06/201805/06/2028USD0USD16.150USD16.15017,433
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
06/06/2018 USD0USD0.000USD16.1509,282
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
05/06/201904/06/2029USD0USD9.230USD9.23064,610
Long position
4108Unlisted derivatives - Other (you must describe the category of derivatives in the Supplementary Information box)
17/06/202116/06/2030USD0USD13.420USD13.42045,383
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Ranjeev Krishana, an employee of Baker Bros. Advisors LP (“BBA”), serves on the Board of Directors of BeiGene, Ltd. as a representative of 667, L.P. and Baker Brothers Life Sciences, L.P. for which he has received stock options (representing 327,418 shares, including options for 45,383 shares granted on Box 1 date) and restricted stock (representing 9,282 shares). The policy of BBA does not entitle him to any pecuniary interest in the stock options and restricted stock for serving as a director.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 22/06/2020
(dd/mm/yyyy)